Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- HIV -1 Infection
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 10 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04050449
- Collaborators
- National Institute of Allergy and Infectious Diseases (NIAID)
- United States President's Emergency Plan for AIDS Relief
- Investigators
- Study Chair: James Hakim, MBChB Parirenyatwa CRS